Follow Us On Facebook
500 W san Bernardino RD, STE A, Covina, CA 91722
Call :
626-966-1909 | Email :
Patient PortalPay NowVirtual Visit


1- Subcategories of Fibromyalgia: A New Concept

2- Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series

3- Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

4- Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis

5- Low Dose Naltrexone in the Treatment of Fibromyalgia

6- Trial of Anifrolumab in Active Systemic Lupus Erythematosus

7- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

8- Combination Therapy of Apremilast and Biologic Agent as a Safe Option of Psoriatic Arthritis and Psoriasis

9- Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomized controlled trial

10- Cryoneurolysis to treat the pain and symptoms of knee osteoarthritis: a multicenter, randomized, double-blind, sham-controlled trial

11- Autoinflammation and Immunomodulation in Inflammatory Fibromyalgia Syndrome- A Review

12- Improvement of Nerve Fiber Density in Fibromyalgia Patients Treated with IVIg.

13- Inflammatory Fibromyalgia: Is it Real?

14- Hip arthroplasty in a 101-year-old patient.

15- Rituximab treatment for resistant antiphospholipid syndrome.

16- Neurosarcoidosis mimicking multiple sclerosis successfully treated with methotrexate and adalimumab

17- Giant cell arteritis with visual loss following zoledronic acid infusion.

18- Pregnancy in a patient with gouty arthritis secondary to pseudo-Bartter syndrome

19- Inflammatory arthritis secondary to metastatic gastric cancer.

20- Infliximab treatment of Familial Mediterranean fever and its effect on secondary AA amyloidosis

21- Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis

22- Anakinra prevents symptoms of familial cold autoinflammatory syndrome and Raynaud’s disease

23- The use of the tumor necrosis factor antagonist infliximab in heart transplant recipients: two case reports

24- B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations

25-  Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus